Montero-Vilchez, TrinidadMartinez-Lopez, AntonioSalvador-Rodriguez, LuisMolina-Leyva, AlejandroArias-Santiago, Salvador2023-02-092023-02-092020-06-17Montero-Vilchez T, Martinez-Lopez A, Salvador-Rodriguez L, Molina-Leyva A, Arias-Santiago S. Management of patients with hidradenitis suppurativa during the COVID-19 pandemic. Dermatol Ther. 2020 Nov;33(6):e13875.http://hdl.handle.net/10668/15769The recent coronavirus disease 2019 (COVID-19) pandemic, caused by the Severe acute respiratory syndrome-associated coronavirus type 2 (SARS-CoV-2) virus, has spread all over the world. As of April 21, 2020, there were 2 478 948 cases of infection, of which 652 046 have resolved, and 170 399 people have died in 185 different countries. The elderly and people with underlying conditions such as cardiovascular disease, obesity, diabetes or cancer are at the highest risk of infection and prone to serious outcomes.enHidradenitis SuppurativaAgedCardiovascular DiseasesPandemicsDeathObesityCOVID-19Hidradenitis SuppurativaHumansSARS-CoV-2research article32558071Restricted AccessHidradenitis supurativaSARS-CoV-2Humanos10.1111/dth.138751529-8019PMC7323050https://europepmc.org/articles/pmc7323050?pdf=renderhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323050/pdf